Carbonic anhydrases: Again, and again, and again

Current Pharmaceutical Design

Volumn 16, Issue 29, 2010, Pages 3231-3232

  Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 PHENYL 1H INDOLE 5 SULFONAMIDE; ACETAZOLAMIDE; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIGLAUCOMA AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; ANTIOBESITY AGENT; ANTIPAIN; BICARBONATE; CARBON DIOXIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; COUMARIN; DIURETIC AGENT; ETHOXZOLAMIDE; PROTON; SULFONAMIDE; TOPIRAMATE; UNCLASSIFIED DRUG; ZONISAMIDE;

ANTINEOPLASTIC ACTIVITY; BRAIN CANCER; BRUCELLA; BRUCELLA SUIS; CANDIDA ALBICANS; CATALYST; COMPETITIVE INHIBITION; CRYPTOCOCCUS NEOFORMANS; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG DESIGN; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HYDRATION; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENETIC TREE; PRIORITY JOURNAL; SCIENTIST;

CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; HUMANS; ISOENZYMES;

EID: 78649894239     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210793429779     Document Type: Editorial

References (13)

1. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7:168-81.
2. Supuran CT, Briganti F, Tilli S, Chegwidden WR, Scozzafava A. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? Bioorg Med Chem 2001; 9: 703-14.
3. Supuran CT, Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010; 16(29): 3233-45.
4. Supuran CT, Di Fiore A, Alterio V, Monti SM, De Simone G. Recent advances in structural studies of the carbonic anhydrase fmily: the crystal structure of human CA IX and CA XIII. Curr Pharm Des 2010; 16(29): 3246-54.
5. Zatovicova M, Jelenska L, Hulikova A, et al. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Curr Pharm Des 2010; 16(29): 3255-63.
6. Aspatwar A, Tolvanen MEE, Ortutay C, Parkkila S. Carbonic anhydrase related protein VIII and its role in neurodegeneration and cancer. Curr Pharm Des 2010; 16(29): 3264-76.
7. Lopez M, Salmon AJ, Supuran CT, Poulsen SA. Carbonic anhydrase inhibitors developed through 'click tailing'. Curr Pharm Des 2010; 16(29): 3277-87.
8. Said HM, Supuran CT, Hageman C, et al. Active Modulation of Hypoxia Induced Human Brain Cancer Regulative Gene Carbonic Anhydrase 9 (CA9) Curr Pharm Des 2010; 3288-99.
9. Nishimori I, Minakuchi T, Maresca A, Carta F, Scozzafava A, Supuran CT. The β-carbonic anhydrases from Mycobacterium tuberculosis as drug targets. Curr Pharm Des 2010; 16(29): 3300-09.
10. Winum JY, Kohler S, Supuran CT. Brucella carbonic anhydrases: New targets for designing anti-infective agents. Curr Pharm Des 2010; 16(29): 3310-16.
11. Güzel Ö, Innocenti A, Vullo D, Scozzafava A, Supuran CT. 3-Phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitors. Curr Pharm Des 2010; 16(29): 3317-26.
12. Isik S, Ozensoy Guler O, Kockar F, Aydin M, Arslan O, Supuran CT. Saccharomyces cerevisiae β-carbonic anhydrase inhibition and activation studies. Curr Pharm Des 2010; 16(29): 3327-36.
13. Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010; 20: 3467-74.